Lamivudine treatment is beneficial in patients with hepatocellular carcinoma.

被引：0
|
作者：
Takagi, S
Fujioka, S
Fujio, K
Kaneyoshi, T
Kobatake, T
Araki, Y
Okamoto, R
Kobashi, H
Hashimoto, K
Senoh, T
Manabe, K
Iwasaki, Y
Shimomura, H
Sakaguchi, K
Shiratori, Y
机构：
[1] Okayama Univ, Sch Med & Dent, Okayama Hepatitis B Res Grp, Okayama, Japan
[2] Okayama Univ, Med Sch Lab Med, Okayama Hepatitis B Res Grp, Okayama, Japan
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2098
引用
收藏
页码：687A / 687A
页数：1
相关论文
共 50 条
  • [41] Success of liver transplantation in patients with multifocal hepatocellular carcinoma.
    Cooper, Amanda B.
    Mangus, Richard S.
    Maluccio, Mary
    Fridell, Jonathan
    Vianna, Rodrigo
    Tector, A. Joseph
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 469 - 469
  • [42] Clinical presentation and diagnostic features of patients with hepatocellular carcinoma.
    Romijn, MG
    Meijssen, MAC
    Bac, DJ
    Lameris, JS
    Tilanus, HW
    Schalm, SW
    Hop, WCJ
    Ijzermans, JNM
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1367 - A1367
  • [43] Antigens recognized by autologous antibody in patients with hepatocellular carcinoma.
    Uemura, M
    Nouso, K
    Kobayashi, Y
    Tanaka, H
    Nakatsukasa, H
    Taniyama, M
    Fujikawa, T
    Matsumoto, E
    Fujiwara, K
    Nakamura, S
    Higashi, T
    Tsuji, T
    [J]. HEPATOLOGY, 2001, 34 (04) : 176A - 176A
  • [44] Hepatitis serology as a prognostic factor in patients with hepatocellular carcinoma.
    Ahmad, SA
    Bilimoria, MM
    Izzo, F
    Delrio, P
    Marra, P
    Baker, TP
    Porter, GA
    Ellis, LM
    Vauthey, JN
    Dhamotharan, S
    Curley, SA
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1036 - A1036
  • [45] Experience of percutaneous radiofrequency ablation for patients with hepatocellular carcinoma.
    Ikehara, T
    Hagiwara, M
    Mori, T
    Nishio, Y
    Kawafune, T
    Ishii, K
    Sumino, Y
    [J]. HEPATOLOGY, 2001, 34 (04) : 182A - 182A
  • [46] The Impact of Locoregional Treatment and Waiting Times in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Lohlun, J.
    Mahawithitwong, P.
    Radosevich, D.
    Chinnakotla, S.
    Pruett, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 246 - 246
  • [47] Treatment of tumour recurrence after resection of hepatocellular carcinoma.: Analysis of 97 consecutive patients
    Tralhao, J. G.
    Dagher, I.
    Lino, T.
    Roudie, J.
    Franco, D.
    [J]. EJSO, 2007, 33 (06): : 746 - 751
  • [48] Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma
    Xu, Xiaojing
    Huang, Peixin
    Tian, Hui
    Chen, Yi
    Ge, Ningling
    Tang, Wengquing
    Yang, Biwei
    Xia, Jinglin
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (06) : 1273 - 1278
  • [49] Liver Transplantation Versus Liver Resection for the Treatment of Hepatocellular Carcinoma.
    Park, Min-Su
    Lee, Kwang-Woong
    Suh, Suk-Won
    You, Tae
    Kim, Hyeyoung
    Choi, YoungRok
    Hong, Geun
    Yi, Nam-Joon
    Suh, Kyung-Suk
    Kwon, Choon-Hyuck David
    Joe, Jae-Won
    Lee, Suk-Koo
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S118 - S119
  • [50] Hepatic resection of hepatocellular carcinoma.
    Que, FG
    Gigot, JF
    Harmsen, WS
    Nagornev, DM
    [J]. HEPATOLOGY, 1997, 26 (04) : 466 - 466
12345